Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "Emergent-Manufacturing-Operations-Baltimore"

2 News Found

Syngene concludes acquisition of biologics manufacturing facility from Emergent BioSolutions
News | March 20, 2025

Syngene concludes acquisition of biologics manufacturing facility from Emergent BioSolutions

The new site will increase Syngene's total single-use bioreactor capacity to 50,000L


Syngene acquires first US biologics facility for $36.5 million
News | March 11, 2025

Syngene acquires first US biologics facility for $36.5 million

Overall investment in the US facility is estimated around US$50 million